Here are 1-3 brief analogies for Omega Healthcare Investors (OHI):

• American Tower for healthcare properties.
• Prologis for nursing homes and assisted living facilities.

• Real Estate Leasing: Omega Healthcare Investors acquires and leases out a portfolio of healthcare facilities, primarily skilled nursing and assisted living facilities, to third-party operators under long-term, triple-net lease agreements.
• Mortgage and Other Debt Financing: The company provides mortgage loans and other forms of debt financing to healthcare operators, often in conjunction with or as an alternative to direct property ownership.

Omega Healthcare Investors (OHI) is a real estate investment trust (REIT) that invests in healthcare facilities, primarily skilled nursing and assisted living facilities. As such, its primary "customers" are the operating companies that lease and manage these facilities.

Based on their 2023 Annual Report (10-K), Omega Healthcare Investors' major customers (operators) and their approximate percentage of annualized contractual rent and mortgage interest revenue as of December 31, 2023, are:

• Maplewood Senior Living (Private Company) - 12.1%
• Guardian Healthcare (Private Company) - 9.1%
• Agemo Group (Private Company) - 8.8%
• Laurel Health Care Company (Private Company) - 7.1%
• CommuniCare Health Services (Private Company) - 5.9%
• Revera Health Services (Private Company) - 5.9%

• PNC Financial Services Group, Inc. (Symbol: PNC)
• Deloitte & Touche LLP

Mr. Pickett has served as Chief Executive Officer of Omega Healthcare Investors since 2001 and as a Director since May 2002. Prior to joining Omega, he was a member of the senior management team of Integrated Health Services, Inc. (IHS) from 1993 to June 2001, where he served most recently as Executive Vice President and Chief Financial Officer. Before his time at IHS, Mr. Pickett held various positions at PHH Corporation and KPMG Peat Marwick. He also serves as a member of the board of trustees for COPT Defense Properties (NYSE:CDP).

Mr. Stephenson has served as Chief Financial Officer of Omega Healthcare Investors since August 2001. From 1996 to July 2001, he was the Senior Vice President and Treasurer of Integrated Health Services, Inc. Prior to joining Integrated Health Services, Inc., Mr. Stephenson held various positions at CSX Intermodal, Inc., Martin Marietta Corporation, and Electronic Data Systems. He also serves on the Board of the University of Maryland Medical Center (UMMC) and was appointed to the Board of Directors for Plymouth Industrial REIT (NYSE:PLYM) in March 2025.

Mr. Gourmand was appointed President in January 2025. He previously served as Senior Vice President of Corporate Strategy & Investor Relations at Omega Healthcare Investors since October 2017. Before joining Omega, Mr. Gourmand spent 10 years as an equity portfolio manager at Millennium Partners and Stevens Capital Management. His prior experience also includes three years as an equity research analyst at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant.

Mr. Gupta was appointed Chief Investment Officer in January 2025. He joined Omega Healthcare Investors in July 2011 and most recently served as Senior Vice President of Acquisitions & Development as of April 2015. From 2003 to July 2011, Mr. Gupta held various roles at CapitalSource Finance, where he oversaw a portfolio of healthcare assets. He currently serves on the Board of Directors for the Foundation for International Medical Relief of Children (“FIMRC”) and the National Investment Center for Seniors Housing & Care (“NIC”), and is on the Executive Board for the American Seniors Housing Association (“ASHA”).

Mr. Ballew joined Omega Healthcare Investors in August 2020 as Chief Accounting Officer, overseeing the accounting and financial reporting functions. Before his tenure at Omega, he spent 10 years in EY's real estate and hospitality audit practice, most recently as a senior manager within EY's professional practice group.

1. Tenant Financial Health and Bankruptcy Risk: Omega Healthcare Investors' business model relies heavily on its tenants, primarily skilled nursing and senior housing operators, consistently paying rent. The financial health of these operators is a critical factor, and any significant financial difficulties, defaults, or bankruptcies among them can directly impact OHI's revenue and profitability. Several tenants have faced issues, including past bankruptcies (e.g., Genesis) and ongoing investigations (e.g., PACS Group, OHI's fifth-largest tenant, which is under investigation for billing practices and has not filed current financials). As of mid-2025, approximately 4.3% of OHI's portfolio rent comes from facilities with an EBITDAR (Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent) coverage below 1.0x, indicating a risk of future non-payment. The concentration of revenue from key operators also poses a risk, as challenges faced by a major tenant could lead to substantial cash flow vulnerability.
2. Regulatory Risks and Government Reimbursement Changes: The healthcare sector is highly regulated, and Omega Healthcare Investors' tenants are significantly dependent on government programs such as Medicare and Medicaid for the bulk of their revenue. Any changes in government policies, reimbursement rates, or stricter regulations can negatively affect the financial performance of these healthcare operators, thereby impacting their ability to meet rent obligations to OHI. The threat of potential funding cuts in Medicare and Medicaid is a constant concern for the industry.
3. Interest Rate Sensitivity: As a real estate investment trust (REIT), Omega Healthcare Investors is sensitive to fluctuations in interest rates. Elevated interest rates increase OHI's cost of capital when issuing new debt, which can compress the spread between their cost of capital and the yield on their investments. Rising interest rates can also negatively impact the profit models of their operators, potentially leading to deferred or partial rent payments, as observed in previous periods. The company also utilizes debt to fund its investments, with a significant amount of long-term debt on its balance sheet, making it susceptible to higher capital costs if rates increase.

The accelerating shift towards home-based healthcare and "aging in place" models, driven by advancements in remote monitoring technologies, telehealth, and evolving payer preferences. This trend makes it increasingly feasible for individuals requiring post-acute care or long-term support to receive services in their homes, thereby reducing the demand for the skilled nursing and assisted living facilities that constitute Omega Healthcare Investors' primary asset base. This structural change in care delivery directly threatens the occupancy rates and long-term viability of traditional institutional care settings.

Omega Healthcare Investors (OHI) primarily invests in and provides financing for skilled nursing facilities (SNFs) and assisted living facilities (ALFs). The addressable markets for these services are substantial within the United States.

U.S. Skilled Nursing Facility Market

The U.S. skilled nursing facility market was valued at approximately USD 180.95 billion in 2023 and is projected to reach around USD 253.77 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 3.44% during this forecast period. Other estimates place the market size at USD 199.72 billion in 2024, with an expected growth to USD 290.02 billion by 2033 at a CAGR of 4.39%. Further data indicates the market was valued at USD 161.9 billion in 2024 and is anticipated to be USD 167.5 billion in 2025. The U.S. skilled nursing facility market size was also evaluated at USD 119.75 billion in 2024 and is predicted to be worth around USD 287.10 billion by 2034, rising at a CAGR of 9.14% from 2025 to 2034.

U.S. Assisted Living Facility Market

The U.S. assisted living market was valued at USD 67.7 billion in 2024 and is projected to grow to approximately USD 108.2 billion by 2034, with a CAGR of 4.8% from 2025 to 2034. Another assessment estimated the market at USD 44.38 billion in 2024, with an expectation to reach USD 93.54 billion by 2033, growing at a CAGR of 8.69%. Additionally, the U.S. assisted living facility market size is valued at USD 103.5 billion in 2024 and is predicted to reach USD 182.3 billion by 2034, at a 5.9% CAGR during the forecast period. The broader U.S. senior living market, which includes assisted living, reached approximately USD 111.20 billion in 2024 and is projected to reach around USD 201.03 billion by 2034, growing at a CAGR of 6.10% between 2025 and 2034.

Share Repurchases

• Omega Healthcare Investors authorized a $500 million share repurchase program in January 2022, which was scheduled to expire in March 2025.
• The company did not repurchase any shares under this program during 2024 or through the first nine months of 2025.

Share Issuance

• In Q1 2025, Omega issued 7 million shares of equity, generating gross proceeds of $264 million.
• The company issued 2 million common shares in Q3 2025 for gross proceeds of $89 million.
• In November 2025, Omega terminated its prior at-the-market (ATM) equity offering sales agreement and entered into a new one, authorizing the sale of common stock not to exceed an aggregate gross sales price of $2 billion.

Outbound Investments

• Year-to-date through Q3 2025, Omega completed approximately $978 million in new investments.
• In Q2 2025, the company acquired a 45-property portfolio of care homes in Scotland and Jersey for $344 million.
• In October 2025, Omega invested $222 million to acquire a 49% equity interest in a real estate joint venture owning 64 healthcare facilities with Sabre Healthcare, and also made a 9.9% equity investment in Sabre's operating company.

Capital Expenditures

• Omega Healthcare Investors invested $85.7 million in construction in progress and capital improvement programs during the nine months ended September 30, 2025.
• The company reported $34 million in capital expenditures during Q1 2025.
• During Q3 2025, an additional $24 million in capital expenditures was noted, separate from new investments.